Evidence map›Paper›PMID 39113899›Full record

ArticleJHEP reports : innovation in hepatology2024

Incidence and prevalence of primary biliary cholangitis in the Netherlands - A nationwide cohort study.

Rozanne C de Veer, Maria C B van Hooff, Ellen Werner, Ulrich Beuers, Joost P H Drenth, Frans J C Cuperus, Bart van Hoek, Bart J Veldt, Michael Klemt-Kropp, Suzanne van Meer and 25 more

Abstract read
In one paragraph

Article in JHEP reports : innovation in hepatology, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

35 authors.

Rozanne C de VeerDepartment of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, the Netherlands.
Maria C B van HooffDepartment of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, the Netherlands.
Ellen WernerDepartment of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, the Netherlands.
Ulrich BeuersDepartment of Gastroenterology and Hepatology, Amsterdam University Medical Center, Amsterdam, the Netherlands.
Joost P H DrenthDepartment of Gastroenterology and Hepatology, Radboud University Medical Center, Nijmegen, the Netherlands.
Frans J C CuperusDepartment of Gastroenterology and Hepatology, University Medical Center Groningen, Groningen, the Netherlands.
Bart van HoekDepartment of Gastroenterology and Hepatology, Leiden University Medical Center, Leiden, the Netherlands.
Bart J VeldtDepartment of Gastroenterology and Hepatology Reinier de Graaf Gasthuis, Delft, the Netherlands.
Michael Klemt-KroppDepartment of Gastroenterology and Hepatology, Noordwest Ziekenhuisgroep, Alkmaar, the Netherlands.
Suzanne van MeerDepartment of Gastroenterology and Hepatology, University Medical Center Utrecht, Utrecht, the Netherlands.
Robert C VerdonkDepartment of Gastroenterology and Hepatology, St. Antonius Hospital, Nieuwegein, the Netherlands.
Hajo J FlinkDepartment of Gastroenterology and Hepatology, Catharina Hospital, Eindhoven, the Netherlands.
Jan Maarten VrolijkDepartment of Gastroenterology and Hepatology, Rijnstate, Arnhem, the Netherlands.
Tom J G GeversDepartment of Gastroenterology and Hepatology, Maastricht University Medical Center, Maastricht, the Netherlands.
Cyriel Y PonsioenDepartment of Gastroenterology and Hepatology, Amsterdam University Medical Center, Amsterdam, the Netherlands.
Martijn J Ter BorgDepartment of Gastroenterology and Hepatology, Maxima Medical Center, Eindhoven, the Netherlands.
Khalida SoufidiDepartment of Gastroenterology and Hepatology, Zuyderland Medical Center, Heerlen, the Netherlands.
Femke BoersmaDepartment of Gastroenterology and Hepatology, Gelre Hospitals, Apeldoorn-Zutphen, the Netherlands.
Hendrik J M de JongeDepartment of Gastroenterology and Hepatology, Jeroen Bosch Hospital, Den Bosch, the Netherlands.
Frank H J WolfhagenDepartment of Gastroenterology and Hepatology, Albert Schweitzer Hospital, Dordrecht, the Netherlands.
L C BaakDepartment of Gastroenterology and Hepatology, Onze Lieve Vrouwe Gasthuis, Amsterdam, the Netherlands.
Susanne L OnderwaterDepartment of Gastroenterology and Hepatology, Diakonessenhuis, Utrecht, the Netherlands.
Jeroen D van BergeijkDepartment of Gastroenterology and Hepatology, Hospital De Gelderse Vallei, Ede, the Netherlands.
Paul G van PuttenDepartment of Gastroenterology and Hepatology, Medical Center Leeuwarden, Leeuwarden, the Netherlands.
Gijs J de BruinDepartment of Gastroenterology and Hepatology, Tergooi Hospital, Hilversum-Blaricum, the Netherlands.
Rob P R AdangDepartment of Gastroenterology and Hepatology, VieCuri, Venlo, the Netherlands.
Maria N Aparicio-PagesDepartment of Gastroenterology and Hepatology, Canisius/Wilhemina Hospital, Nijmegen, the Netherlands.
Wink de BoerDepartment of Gastroenterology and Hepatology, Bernhoven, Uden, the Netherlands.
Frank Ter BorgDepartment of Gastroenterology and Hepatology, Deventer Hospital, Deventer, the Netherlands.
Hanneke van SoestDepartment of Gastroenterology and Hepatology, Medical Center Haaglanden, Den Haag, the Netherlands.
Harry L A JanssenDepartment of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, the Netherlands.
Bettina E HansenDepartment of Biostatistics, Erasmus University Medical Center, Rotterdam, the Netherlands.
Nicole S ErlerDepartment of Biostatistics, Erasmus University Medical Center, Rotterdam, the Netherlands.
Adriaan J van der MeerDepartment of Gastroenterology and Hepatology, Erasmus University Medical Center, Rotterdam, the Netherlands.
Dutch PBC Study Group

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background & Aims: Although primary biliary cholangitis (PBC) is considered a rare disorder, accurate determination of its incidence and prevalence remains challenging due to limited comprehensive population-based registries. We aimed to assess the incidence and prevalence of PBC in the Netherlands over time through the nationwide Dutch PBC Cohort Study (DPCS). Methods: DPCS retrospectively included every identifiable patient with PBC in the Netherlands from 1990 onwards in all 71 Dutch hospitals. Incidence and prevalence were assessed between 2008-2018 by Poisson regression between sex and age groups over time. Results: On the 1 Conclusions: In this nationwide cohort study, we observed an increase in both the incidence and prevalence of PBC in the Netherlands over the past decade, with marked age and sex differences. Impact and implications: This nationwide Dutch primary biliary cholangitis (PBC) Cohort Study, including all hospitals in the Netherlands, showed that the incidence and prevalence of PBC have increased over the last decade. The age-dependent PBC incidence rate differed for males (highest risk ≥65 years) and females (highest risk between 45 and 65 years), which may be related to a difference in the timing of exposure to environmental triggers of PBC. The largest increase in PBC prevalence over time was observed in the population aged ≥65 years, which may have implications for the use of second-line therapies. These results therefore indicate that further studies are needed to elaborate on the advantages and disadvantages of add-on therapies in the elderly population.

Indexed as

IncidencePrevalencePrimary biliary cholangitis

Identifiers

PMID39113899
PMCPMC11304051

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.